The medical treatment of the hypersecreting pituitary gland.
Pituitary adenomas may produce local endocrine and neurological effects, as well as systemic metabolic complications due to hormonal hypersecretion. Medical therapy with pharmacological agents has been developed and is based on the neurotransmitter regulation of normal pituitary hormonal secretion. 189 patients with secretory pituitary adenomas underwent medical therapy for the hypersecretory state. 156 of these were prolactin-secreting adenomas, 16 of which were in males. The response of bromocriptine was almost universal with lowering of serum prolactin and reversal of the clinical symptoms, as well as tumor shrinkage of most large adenomas with suprasellar extension. 23 patients with acromegaly were treated with bromocriptine, with 11 noting clinical improvement, and decreased tumor size in two. Five patients with Cushing's disease were treated with cyproheptadine, with only one showing a biochemical and clinical improvement. Two patients with Nelson's syndrome each had progressive tumor growth stabilized with cyproheptadine and bromocriptine in one, and sodium valproate in the other. There appears to be a role for medical therapy in the majority of prolactin-secreting pituitary tumors, some growth hormone secreting pituitary tumors, and selected adrenocorticotropin secreting-pituitary tumors.
D000236:Adenoma / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology; D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000328:Adult; D000368:Aged; D001971:Bromocriptine / Q000627:therapeutic use; D003533:Cyproheptadine / Q000627:therapeutic use; D004873:Ergolines / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010479:Pergolide; D010902:Pituitary Gland / Q000378:metabolism* / Q000503:physiopathology; D010911:Pituitary Neoplasms / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology; D011388:Prolactin / Q000378:metabolism; D014635:Valproic Acid / Q000627:therapeutic use
D004873:Ergolines; D010479:Pergolide; D003533:Cyproheptadine; D001971:Bromocriptine; D014635:Valproic Acid; D000324:Adrenocorticotropic Hormone; D011388:Prolactin